Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 293

1.

Concise Review: Exploring immunomodulatory features of Mesenchymal Stromal Cells in humanized mouse models.

Mehler VJ, Burns CJ, Moore ML.

Stem Cells. 2018 Nov 5. doi: 10.1002/stem.2948. [Epub ahead of print] Review.

PMID:
30395373
2.

Precision of Dual-Energy X-Ray Absorptiometry Reflection Scans in Muscular Athletes.

Tinsley GM, Moore ML, Graybeal AJ.

J Clin Densitom. 2018 Sep 13. pii: S1094-6950(18)30172-0. doi: 10.1016/j.jocd.2018.09.005. [Epub ahead of print]

PMID:
30327241
3.

Resting metabolic rate in muscular physique athletes: validity of existing methods and development of new prediction equations.

Tinsley GM, Graybeal AJ, Moore ML.

Appl Physiol Nutr Metab. 2018 Sep 21. doi: 10.1139/apnm-2018-0412. [Epub ahead of print]

PMID:
30240568
4.

Body Composition Assessment in Male and Female Bodybuilders: A 4-Compartment Model Comparison of Dual-Energy X-Ray Absorptiometry and Impedance-Based Devices.

Graybeal AJ, Moore ML, Cruz MR, Tinsley GM.

J Strength Cond Res. 2018 Aug 29. doi: 10.1519/JSC.0000000000002831. [Epub ahead of print]

PMID:
30161092
5.

The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography.

Ke Z, Dillard RS, Chirkova T, Leon F, Stobart CC, Hampton CM, Strauss JD, Rajan D, Rostad CA, Taylor JV, Yi H, Shah R, Jin M, Hartert TV, Peebles RS Jr, Graham BS, Moore ML, Anderson LJ, Wright ER.

Viruses. 2018 Aug 20;10(8). pii: E446. doi: 10.3390/v10080446.

6.

Fat-free Mass Characteristics of Muscular Physique Athletes.

Tinsley GM, Graybeal AJ, Moore ML, Nickerson BS.

Med Sci Sports Exerc. 2018 Aug 7. doi: 10.1249/MSS.0000000000001749. [Epub ahead of print]

PMID:
30095745
7.

Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses.

Yoon JJ, Toots M, Lee S, Lee ME, Ludeke B, Luczo JM, Ganti K, Cox RM, Sticher ZM, Edpuganti V, Mitchell DG, Lockwood MA, Kolykhalov AA, Greninger AL, Moore ML, Painter GR, Lowen AC, Tompkins SM, Fearns R, Natchus MG, Plemper RK.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00766-18. doi: 10.1128/AAC.00766-18. Print 2018 Aug.

PMID:
29891600
8.

Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."

Thomas DE, Kaimakliotis HZ, Rice KR, Pereira JA, Johnston P, Moore ML, Reed A, Cregar DM, Franklin C, Loman RL, Koch MO, Bihrle R, Foster RS, Masterson TA, Gardner TA, Sundaram CP, Powell CR, Beck S, Grignon DJ, Cheng L, Albany C, Hahn NM.

Urol Oncol. 2018 Jul;36(7):345. doi: 10.1016/j.urolonc.2018.05.003. Epub 2018 Jun 5.

PMID:
29880459
9.

Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze.

Turi KN, Shankar J, Anderson LJ, Rajan D, Gaston K, Gebretsadik T, Das SR, Stone C, Larkin EK, Rosas-Salazar C, Brunwasser SM, Moore ML, Peebles RS Jr, Hartert TV.

Am J Respir Crit Care Med. 2018 Oct 15;198(8):1064-1073. doi: 10.1164/rccm.201711-2348OC.

PMID:
29733679
10.

Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology.

Bloodworth MH, Rusznak M, Pfister CC, Zhang J, Bastarache L, Calvillo SA, Chappell JD, Boyd KL, Toki S, Newcomb DC, Stier MT, Zhou W, Goleniewska K, Moore ML, Hartert TV, Niswender KD, Peebles RS Jr.

J Allergy Clin Immunol. 2018 Aug;142(2):683-687.e12. doi: 10.1016/j.jaci.2018.01.053. Epub 2018 Apr 17. No abstract available.

PMID:
29678751
11.

Polyvalent vaccines: High-maintenance heroes.

Schlingmann B, Castiglia KR, Stobart CC, Moore ML.

PLoS Pathog. 2018 Apr 5;14(4):e1006904. doi: 10.1371/journal.ppat.1006904. eCollection 2018 Apr. Review. No abstract available.

12.

Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins.

Mousa JJ, Binshtein E, Human S, Fong RH, Alvarado G, Doranz BJ, Moore ML, Ohi MD, Crowe JE Jr.

PLoS Pathog. 2018 Feb 22;14(2):e1006837. doi: 10.1371/journal.ppat.1006837. eCollection 2018 Feb.

13.

Improving communication between obstetric and neonatology teams for high-risk deliveries: a quality improvement project.

Sundgren NC, Kelly FC, Weber EM, Moore ML, Gokulakrishnan G, Hagan JL, Brand MC, Gallegos JO, Levy BE, Fortunov RM.

BMJ Open Qual. 2017 Dec 14;6(2):e000095. doi: 10.1136/bmjoq-2017-000095. eCollection 2017.

14.

Reliability of hunger-related assessments during 24-hour fasts and their relationship to body composition and subsequent energy compensation.

Tinsley GM, Moore ML, Graybeal AJ.

Physiol Behav. 2018 May 1;188:221-226. doi: 10.1016/j.physbeh.2018.02.017. Epub 2018 Feb 10.

PMID:
29438660
15.

Nasopharyngeal Lactobacillus is associated with a reduced risk of childhood wheezing illnesses following acute respiratory syncytial virus infection in infancy.

Rosas-Salazar C, Shilts MH, Tovchigrechko A, Schobel S, Chappell JD, Larkin EK, Gebretsadik T, Halpin RA, Nelson KE, Moore ML, Anderson LJ, Peebles RS Jr, Das SR, Hartert TV.

J Allergy Clin Immunol. 2018 Nov;142(5):1447-1456.e9. doi: 10.1016/j.jaci.2017.10.049. Epub 2018 Jan 10.

16.

Enhancing the Thermostability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Live-Attenuated Vaccine by Incorporating Unique RSV Line19F Protein Residues.

Rostad CA, Stobart CC, Todd SO, Molina SA, Lee S, Blanco JCG, Moore ML.

J Virol. 2018 Feb 26;92(6). pii: e01568-17. doi: 10.1128/JVI.01568-17. Print 2018 Mar 15.

17.

Rhinovirus Biology, Antigenic Diversity, and Advancements in the Design of a Human Rhinovirus Vaccine.

Stobart CC, Nosek JM, Moore ML.

Front Microbiol. 2017 Dec 5;8:2412. doi: 10.3389/fmicb.2017.02412. eCollection 2017.

18.

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein.

Tian D, Battles MB, Moin SM, Chen M, Modjarrad K, Kumar A, Kanekiyo M, Graepel KW, Taher NM, Hotard AL, Moore ML, Zhao M, Zheng ZZ, Xia NS, McLellan JS, Graham BS.

Nat Commun. 2017 Nov 30;8(1):1877. doi: 10.1038/s41467-017-01858-w.

19.

Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses.

Chatterjee S, Luthra P, Esaulova E, Agapov E, Yen BC, Borek DM, Edwards MR, Mittal A, Jordan DS, Ramanan P, Moore ML, Pappu RV, Holtzman MJ, Artyomov MN, Basler CF, Amarasinghe GK, Leung DW.

Nat Microbiol. 2017 Jun 30;2:17101. doi: 10.1038/nmicrobiol.2017.101.

20.

STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection.

Stier MT, Goleniewska K, Cephus JY, Newcomb DC, Sherrill TP, Boyd KL, Bloodworth MH, Moore ML, Chen K, Kolls JK, Peebles RS Jr.

J Immunol. 2017 Jul 15;199(2):510-519. doi: 10.4049/jimmunol.1601984. Epub 2017 Jun 2.

21.

BAC-Based Recovery of Recombinant Respiratory Syncytial Virus (RSV).

Stobart CC, Hotard AL, Meng J, Moore ML.

Methods Mol Biol. 2017;1602:111-124. doi: 10.1007/978-1-4939-6964-7_8.

PMID:
28508217
22.

Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein.

Leemans A, De Schryver M, Van der Gucht W, Heykers A, Pintelon I, Hotard AL, Moore ML, Melero JA, McLellan JS, Graham BS, Broadbent L, Power UF, Caljon G, Cos P, Maes L, Delputte P.

J Virol. 2017 Jun 26;91(14). pii: e00184-17. doi: 10.1128/JVI.00184-17. Print 2017 Jul 15.

23.

Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy.

Achten NB, Wu P, Bont L, Blanken MO, Gebretsadik T, Chappell JD, Wang L, Yu C, Larkin EK, Carroll KN, Anderson LJ, Moore ML, Sloan CD, Hartert TV.

J Infect Dis. 2017 Apr 1;215(7):1102-1106. doi: 10.1093/infdis/jix031.

24.

Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective.

Boyoglu-Barnum S, Todd SO, Meng J, Barnum TR, Chirkova T, Haynes LM, Jadhao SJ, Tripp RA, Oomens AG, Moore ML, Anderson LJ.

J Virol. 2017 Apr 28;91(10). pii: e02059-16. doi: 10.1128/JVI.02059-16. Print 2017 May 15.

25.

Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.

Hwang HS, Kim KH, Lee Y, Lee YT, Ko EJ, Park S, Lee JS, Lee BC, Kwon YM, Moore ML, Kang SM.

Hum Vaccin Immunother. 2017 May 4;13(5):1031-1039. doi: 10.1080/21645515.2016.1272743. Epub 2017 Jan 27.

26.

Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy.

Thomas DE, Kaimakliotis HZ, Rice KR, Pereira JA, Johnston P, Moore ML, Reed A, Cregar DM, Franklin C, Loman RL, Koch MO, Bihrle R, Foster RS, Masterson TA, Gardner TA, Sundaram CP, Powell CR, Beck SDW, Grignon DJ, Cheng L, Albany C, Hahn NM.

Clin Genitourin Cancer. 2017 Aug;15(4):479-486. doi: 10.1016/j.clgc.2016.11.009. Epub 2016 Nov 30.

27.

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation.

Stobart CC, Rostad CA, Ke Z, Dillard RS, Hampton CM, Strauss JD, Yi H, Hotard AL, Meng J, Pickles RJ, Sakamoto K, Lee S, Currier MG, Moin SM, Graham BS, Boukhvalova MS, Gilbert BE, Blanco JC, Piedra PA, Wright ER, Moore ML.

Nat Commun. 2016 Dec 21;7:13916. doi: 10.1038/ncomms13916.

28.

A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157.

Hahn NM, Bivalacqua TJ, Ross AE, Netto GJ, Baras A, Park JC, Chapman C, Masterson TA, Koch MO, Bihrle R, Foster RS, Gardner TA, Cheng L, Jones DR, McElyea K, Sandusky GE, Breen T, Liu Z, Albany C, Moore ML, Loman RL, Reed A, Turner SA, De Abreu FB, Gallagher T, Tsongalis GJ, Plimack ER, Greenberg RE, Geynisman DM.

Clin Cancer Res. 2017 Jun 15;23(12):3003-3011. doi: 10.1158/1078-0432.CCR-16-2267. Epub 2016 Dec 8.

29.

Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in Infancy.

Rosas-Salazar C, Shilts MH, Tovchigrechko A, Schobel S, Chappell JD, Larkin EK, Shankar J, Yooseph S, Nelson KE, Halpin RA, Moore ML, Anderson LJ, Peebles RS Jr, Das SR, Hartert TV.

J Infect Dis. 2016 Dec 15;214(12):1924-1928.

30.

Caring for Your Most Important Patient: You.

Moore ML.

Home Healthc Now. 2016 Nov/Dec;34(10):577. No abstract available.

PMID:
27805940
31.

Respiratory Syncytial Virus-Infected Mesenchymal Stem Cells Regulate Immunity via Interferon Beta and Indoleamine-2,3-Dioxygenase.

Cheung MB, Sampayo-Escobar V, Green R, Moore ML, Mohapatra S, Mohapatra SS.

PLoS One. 2016 Oct 3;11(10):e0163709. doi: 10.1371/journal.pone.0163709. eCollection 2016.

32.

A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques.

Lee S, Nguyen MT, Currier MG, Jenkins JB, Strobert EA, Kajon AE, Madan-Lala R, Bochkov YA, Gern JE, Roy K, Lu X, Erdman DD, Spearman P, Moore ML.

Nat Commun. 2016 Sep 22;7:12838. doi: 10.1038/ncomms12838.

33.

Mental engagement during cognitive and psychomotor tasks: Effects of task type, processing demands, and practice.

Pendleton DM, Sakalik ML, Moore ML, Tomporowski PD.

Int J Psychophysiol. 2016 Nov;109:124-131. doi: 10.1016/j.ijpsycho.2016.08.012. Epub 2016 Aug 29.

PMID:
27585951
34.

Fluorescent and Bioluminescent Reporter Myxoviruses.

Rostad CA, Currier MC, Moore ML.

Viruses. 2016 Aug 4;8(8). pii: E214. doi: 10.3390/v8080214. Review.

35.

Reverse Genetics of Respiratory Syncytial Virus.

Stobart CC, Hotard AL, Meng J, Moore ML.

Methods Mol Biol. 2016;1442:141-53. doi: 10.1007/978-1-4939-3687-8_10.

PMID:
27464692
36.

A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats.

Rostad CA, Stobart CC, Gilbert BE, Pickles RJ, Hotard AL, Meng J, Blanco JCG, Moin SM, Graham BS, Piedra PA, Moore ML.

J Virol. 2016 Jul 27;90(16):7508-7518. doi: 10.1128/JVI.00012-16. Print 2016 Aug 15.

37.

Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene.

Schobel SA, Stucker KM, Moore ML, Anderson LJ, Larkin EK, Shankar J, Bera J, Puri V, Shilts MH, Rosas-Salazar C, Halpin RA, Fedorova N, Shrivastava S, Stockwell TB, Peebles RS, Hartert TV, Das SR.

Sci Rep. 2016 May 23;6:26311. doi: 10.1038/srep26311.

38.

Nasopharyngeal Microbiome in Respiratory Syncytial Virus Resembles Profile Associated with Increased Childhood Asthma Risk.

Rosas-Salazar C, Shilts MH, Tovchigrechko A, Chappell JD, Larkin EK, Nelson KE, Moore ML, Anderson LJ, Das SR, Hartert TV.

Am J Respir Crit Care Med. 2016 May 15;193(10):1180-3. doi: 10.1164/rccm.201512-2350LE. No abstract available.

39.

Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin.

Stier MT, Bloodworth MH, Toki S, Newcomb DC, Goleniewska K, Boyd KL, Quitalig M, Hotard AL, Moore ML, Hartert TV, Zhou B, McKenzie AN, Peebles RS Jr.

J Allergy Clin Immunol. 2016 Sep;138(3):814-824.e11. doi: 10.1016/j.jaci.2016.01.050. Epub 2016 Apr 9.

40.

EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression.

Currier MG, Lee S, Stobart CC, Hotard AL, Villenave R, Meng J, Pretto CD, Shields MD, Nguyen MT, Todd SO, Chi MH, Hammonds J, Krumm SA, Spearman P, Plemper RK, Sakamoto K, Peebles RS Jr, Power UF, Moore ML.

PLoS Pathog. 2016 May 6;12(5):e1005622. doi: 10.1371/journal.ppat.1005622. eCollection 2016 May.

41.

Priming of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM).

Dyer KD, Drummond RA, Rice TA, Percopo CM, Brenner TA, Barisas DA, Karpe KA, Moore ML, Rosenberg HF.

J Virol. 2015 Nov 4;90(2):979-91. doi: 10.1128/JVI.02279-15. Print 2016 Jan 15.

42.

Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein.

Meng J, Hotard AL, Currier MG, Lee S, Stobart CC, Moore ML.

J Virol. 2015 Oct 14;90(1):245-53. doi: 10.1128/JVI.02140-15. Print 2016 Jan 1.

43.

Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genes.

Stobart CC, Moore ML.

Expert Rev Vaccines. 2015;14(12):1563-72. doi: 10.1586/14760584.2015.1095096. Epub 2015 Oct 5. Review.

44.

Minimally Invasive Sampling Method Identifies Differences in Taxonomic Richness of Nasal Microbiomes in Young Infants Associated with Mode of Delivery.

Shilts MH, Rosas-Salazar C, Tovchigrechko A, Larkin EK, Torralba M, Akopov A, Halpin R, Peebles RS, Moore ML, Anderson LJ, Nelson KE, Hartert TV, Das SR.

Microb Ecol. 2016 Jan;71(1):233-42. doi: 10.1007/s00248-015-0663-y. Epub 2015 Sep 14.

45.

CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.

Chirkova T, Lin S, Oomens AG, Gaston KA, Boyoglu-Barnum S, Meng J, Stobart CC, Cotton CU, Hartert TV, Moore ML, Ziady AG, Anderson LJ.

J Gen Virol. 2015 Sep;96(9):2543-56. doi: 10.1099/vir.0.000218. Epub 2015 Jun 25.

46.

Mammalian Cell-Derived Respiratory Syncytial Virus-Like Particles Protect the Lower as well as the Upper Respiratory Tract.

Walpita P, Johns LM, Tandon R, Moore ML.

PLoS One. 2015 Jul 14;10(7):e0130755. doi: 10.1371/journal.pone.0130755. eCollection 2015.

47.

Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate.

Deval J, Hong J, Wang G, Taylor J, Smith LK, Fung A, Stevens SK, Liu H, Jin Z, Dyatkina N, Prhavc M, Stoycheva AD, Serebryany V, Liu J, Smith DB, Tam Y, Zhang Q, Moore ML, Fearns R, Chanda SM, Blatt LM, Symons JA, Beigelman L.

PLoS Pathog. 2015 Jun 22;11(6):e1004995. doi: 10.1371/journal.ppat.1004995. eCollection 2015 Jun.

48.

RSV-Induced H3K4 Demethylase KDM5B Leads to Regulation of Dendritic Cell-Derived Innate Cytokines and Exacerbates Pathogenesis In Vivo.

Ptaschinski C, Mukherjee S, Moore ML, Albert M, Helin K, Kunkel SL, Lukacs NW.

PLoS Pathog. 2015 Jun 17;11(6):e1004978. doi: 10.1371/journal.ppat.1004978. eCollection 2015 Jun.

49.

Objectives, design and enrollment results from the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE).

Larkin EK, Gebretsadik T, Moore ML, Anderson LJ, Dupont WD, Chappell JD, Minton PA, Peebles RS Jr, Moore PE, Valet RS, Arnold DH, Rosas-Salazar C, Das SR, Polack FP, Hartert TV; INSPIRE Study.

BMC Pulm Med. 2015 Apr 30;15:45. doi: 10.1186/s12890-015-0040-0.

50.

Functional Analysis of the 60-Nucleotide Duplication in the Respiratory Syncytial Virus Buenos Aires Strain Attachment Glycoprotein.

Hotard AL, Laikhter E, Brooks K, Hartert TV, Moore ML.

J Virol. 2015 Aug;89(16):8258-66. doi: 10.1128/JVI.01045-15. Epub 2015 May 27.

Supplemental Content

Loading ...
Support Center